Zevra Therapeutics Files Proxy Statement
Ticker: ZVRA · Form: DEFA14A · Filed: Mar 31, 2025 · CIK: 1434647
| Field | Detail |
|---|---|
| Company | Zevra Therapeutics, Inc. (ZVRA) |
| Form Type | DEFA14A |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, company-update
Related Tickers: ZEVRA
TL;DR
Zevra (ZEVRA) filed its proxy statement, no fee paid.
AI Summary
Zevra Therapeutics, Inc. (formerly KemPharm, Inc.) filed a DEFA14A proxy statement on March 31, 2025. The filing indicates no fee was required for this submission. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing is a routine regulatory document that provides information to shareholders regarding company matters, typically related to annual meetings or significant corporate actions.
Risk Assessment
Risk Level: low — This filing is a standard regulatory disclosure and does not inherently present new financial risks.
Key Players & Entities
- ZEVRA THERAPEUTICS, INC. (company) — Registrant
- KEMPHARM, INC (company) — Former company name
- 0001193125-25-068853 (filing_id) — Accession Number
- 20250331 (date) — Filing Date
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a proxy statement required by the SEC, providing shareholders with information necessary to vote on company matters, such as director elections or other proposals.
When was this DEFA14A filed by Zevra Therapeutics, Inc.?
This DEFA14A was filed on March 31, 2025.
Has Zevra Therapeutics, Inc. undergone any previous name changes?
Yes, Zevra Therapeutics, Inc. was formerly known as KEMPHARM, INC, with a name change date of May 30, 2013.
What is Zevra Therapeutics, Inc.'s standard industrial classification?
Zevra Therapeutics, Inc. falls under the Pharmaceutical Preparations [2834] standard industrial classification.
What is the business address of Zevra Therapeutics, Inc.?
The business address is 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 31, 2025 regarding ZEVRA THERAPEUTICS, INC. (ZVRA).